25 Leading RNA Analysis Companies Shaping Innovation and Market Growth to 2028

Discover the top 25 companies driving innovation in the RNA Analysis market. This in-depth analysis explores competitive advantages, transformative trends, and key players poised to influence global transcriptomics and RNA biology through 2028. Download PDF Brochure of RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028

Spotlights on the Industry's Top RNA Analysis Companies

The RNA analysis market is advancing at a remarkable pace, powered by intensifying R&D activities in transcriptomics, RNA therapeutics, and precision medicine; increasing government funding for drug discovery research; and the growing scale and ambition of global pharmaceutical and biological industries. The global RNA analysis market, valued at USD 4.8 billion in 2022, reached USD 5.3 billion in 2023 and is projected to grow at a CAGR of 13.4% to reach USD 9.9 billion by 2028. This exceptional growth trajectory reflects the expanding role of RNA analysis across drug target identification, biomarker discovery, clinical diagnostics, and the development of RNA-based therapeutics including mRNA vaccines, siRNA, antisense oligonucleotides, and CRISPR-associated RNA tools. Many peptide-based research projects are also being advanced through increasing collaborative partnerships among companies, further stimulating demand for sophisticated RNA analysis technologies and services. In this dynamic environment, the following 25 industry leaders stand out for their scientific depth, technological innovation, and transformative contributions to the global RNA analysis ecosystem.

1. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is the dominant force in the RNA analysis market, offering an unmatched portfolio of products spanning RNA extraction and purification kits, reverse transcription reagents, qRT-PCR master mixes, RNA sequencing library preparation solutions, and comprehensive transcriptomics platforms. Their Invitrogen, Applied Biosystems, and Ambion brands are synonymous with RNA research quality, underpinning workflows in academic, pharmaceutical, and clinical laboratories across the globe. Thermo Fisher's vertically integrated supply chain, global commercial infrastructure, and continuous investment in next-generation RNA analysis technologies—including spatial transcriptomics and single-cell RNA profiling—cement their leadership position across every dimension of the RNA analysis value chain.

2. F. Hoffmann-La Roche Ltd.

Hoffmann-La Roche Ltd. brings its formidable diagnostics and pharmaceutical heritage to the RNA analysis market through its proprietary PCR instruments, LightCycler platforms, and a broad range of RNA quantification and expression analysis reagents widely deployed in research and clinical settings. Roche's cobas and AVENIO platforms extend RNA analysis into oncology companion diagnostics and liquid biopsy applications, where RNA biomarkers play an increasingly central role in treatment selection and disease monitoring. Roche's unique dual identity as both a pharma innovator and a global diagnostics leader enables seamless integration of RNA analysis capabilities into drug discovery pipelines and clinical trial programs, reinforcing their strategic relevance across the RNA analysis ecosystem.

3. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a cornerstone of the RNA analysis market through its industry-leading digital droplet PCR (ddPCR) technology, qPCR instruments and reagents, and RNA gel electrophoresis systems that are standard tools in research and clinical laboratories worldwide. Their QX200 and QX600 Droplet Digital PCR systems enable highly precise quantification of RNA targets at sensitivities unachievable by conventional qPCR, making them indispensable for liquid biopsy, rare transcript detection, and gene expression research. Bio-Rad's long-standing reputation for product quality, scientific rigor, and customer support sustains deep loyalty among RNA researchers and clinical laboratory scientists globally.

4. Illumina, Inc.

Illumina, Inc. is the foundational platform for RNA sequencing, with its short-read sequencing technology enabling whole transcriptome analysis, mRNA expression profiling, small RNA discovery, and single-cell RNA sequencing at scales and costs that have transformed transcriptomics research globally. Their TruSeq, TruSight, and Stranded RNA sequencing library preparation kits, combined with the NovaSeq X and NextSeq platforms, support RNA analysis workflows ranging from discovery research to clinical diagnostic applications. Illumina's continuous investment in sequencing throughput, read quality, and data analysis software—including DRAGEN bioinformatics—keeps them at the center of the RNA analysis universe as transcriptomics applications expand from research into medicine.

5. Eurofins Scientific

Eurofins Scientific is a global leader in contract testing and genomics services with extensive RNA analysis capabilities spanning transcriptomics, gene expression profiling, microRNA analysis, and RNA sequencing services delivered through its worldwide laboratory network. Their RNA analysis services support pharmaceutical and biotechnology clients across drug discovery, biomarker identification, clinical trial sample analysis, and regulatory submission workflows. Eurofins' combination of scientific breadth, international quality standards, rapid turnaround capabilities, and competitive pricing makes them one of the most comprehensive and accessible RNA analysis service providers available to the global life science research community.

6. Agilent Technologies, Inc.

Agilent Technologies, Inc. is a critical enabler of RNA analysis through its Bioanalyzer and TapeStation platforms—the global standard for RNA quality assessment prior to sequencing and expression analysis—as well as its SurePrint microarray technology and RNA target enrichment solutions. The Agilent RNA 6000 Nano and Pico assays provide researchers with rapid, accurate RNA integrity number (RIN) assessment that determines sample quality and downstream analysis suitability. Agilent's deep expertise in nucleic acid measurement, microarray design, and hybridization capture chemistry supports RNA analysis workflows from quality control through targeted sequencing and expression profiling across research and clinical laboratory environments.

7. CD Genomics

CD Genomics is a specialized genomics and transcriptomics services company offering a comprehensive menu of RNA analysis services including bulk RNA sequencing, single-cell RNA sequencing, small RNA profiling, long-read RNA sequencing, and epigenomics services to academic and biopharmaceutical research customers globally. Their technical expertise across diverse RNA analysis modalities, combined with competitive service pricing and responsive project management, has earned CD Genomics a growing international customer base among researchers seeking high-quality transcriptomics data without the capital investment of in-house sequencing infrastructure. CD Genomics' expanding bioinformatics capabilities and data interpretation services further enhance their value as an end-to-end RNA analysis partner.

8. Promega Corporation

Promega Corporation is a trusted RNA analysis reagent supplier with a portfolio spanning RNA isolation kits, reverse transcriptase enzymes, RT-PCR master mixes, RNA quantification assays, and cell-free RNA analysis solutions widely used in research and clinical laboratory workflows. Their Maxwell automated nucleic acid purification systems deliver consistent, operator-independent RNA extraction critical for reproducible downstream analysis from diverse biological sample types. Promega's commitment to enzyme innovation, reagent consistency, and rigorous lot-to-lot quality control has established them as a preferred RNA reagent supplier for researchers and clinical laboratory scientists who prioritize reliability in their RNA analysis workflows.

9. QIAGEN N.V.

QIAGEN N.V. is a global RNA analysis leader whose sample technology portfolio—including the RNeasy, miRNeasy, and PAXgene RNA stabilization systems—has defined best practices in RNA isolation, stabilization, and quality assurance for decades. Their QIAseq RNA library preparation kits, miRNA sequencing panels, and targeted RNA expression panels extend QIAGEN's RNA analysis solutions from sample preparation through sequencing-ready library generation. QIAGEN's unique insight into the critical importance of pre-analytical sample quality, combined with their comprehensive RNA workflow solutions and bioinformatics data interpretation tools, positions them as the most complete single-source provider of RNA analysis solutions from sample to insight.

10. Danaher Corporation

Danaher Corporation participates in the RNA analysis market through its Integrated DNA Technologies (IDT) subsidiary—a leading supplier of RNA oligonucleotides, antisense probes, custom RNA synthesis, and xGen hybridization capture reagents widely used in transcriptomics and RNA sequencing workflows. Danaher's Cytiva brand further contributes RNA-relevant bioprocessing tools for biologic drug discovery and development programs where RNA analysis is an essential component of target identification and therapeutic validation. Danaher's powerful portfolio company operating model, combined with the market leadership of IDT in nucleic acid synthesis and RNA tools, ensures a sustained and growing contribution to the global RNA analysis ecosystem.

11. Merck KGaA

Merck KGaA contributes to the RNA analysis market through its MilliporeSigma brand, which supplies a comprehensive range of RNA research reagents including RNA isolation kits, PCR reagents, hybridization probes, and RNA sequencing library preparation products that support transcriptomics workflows across research and pharmaceutical development settings. Their Sigma-Aldrich catalog of RNA-related research chemicals, enzymes, and molecular biology tools represents one of the broadest single-source collections of RNA analysis inputs available to the scientific community. Merck KGaA's growing investment in RNA therapeutics and oligonucleotide chemistry further deepens their engagement with the RNA analysis ecosystem as both a tools provider and a biopharma innovator.

12. Standard BioTools Inc. (Fluidigm Corporation)

Standard BioTools Inc., formerly Fluidigm Corporation, has developed microfluidics-based platforms that enable highly multiplexed gene expression analysis and single-cell RNA profiling with exceptional precision and efficiency. Their Biomark HD system and Juno integrated fluidic circuit technology support targeted RNA expression analysis across thousands of single cells simultaneously, enabling researchers to resolve cellular heterogeneity in complex biological systems. Standard BioTools' focus on high-dimensional, single-cell and multi-omics analysis positions them at the frontier of RNA analysis applications in immunology, oncology, and developmental biology research where understanding cell-by-cell transcriptional diversity is scientifically essential.

13. Sequentia Biotech SL

Sequentia Biotech SL is a Spanish bioinformatics and transcriptomics company offering specialized RNA sequencing data analysis services, bioinformatics pipeline development, and computational transcriptomics expertise to academic and industry research clients across Europe and globally. Their deep computational biology capabilities in differential gene expression analysis, alternative splicing characterization, and non-coding RNA profiling address the growing need for expert data interpretation that complements the rapid expansion of RNA sequencing data generation. Sequentia Biotech's scientific specialization, flexible service model, and strong publication record in transcriptomics research make them a valued partner for researchers seeking rigorous analytical support for complex RNA analysis projects.

14. Acobiom

Acobiom is a French RNA biomarker discovery and diagnostics company focused on developing minimally invasive RNA-based diagnostic tests from blood and other liquid biopsy specimens for cancer detection, disease monitoring, and treatment response assessment. Their proprietary RNA biomarker discovery platform and bioinformatics capabilities enable the identification and validation of clinically actionable RNA signatures from circulating cells and cell-free RNA in blood. Acobiom's translational focus—bridging RNA analysis science with clinical diagnostic utility—positions them as an innovative contributor to the emerging field of RNA-based liquid biopsy diagnostics, where the promise of earlier and less invasive disease detection is driving significant research and commercial investment.

15. GenXPro GmbH

GenXPro GmbH is a German genomics and transcriptomics service company specializing in RNA sequencing, gene expression profiling, small RNA analysis, and proprietary MACE-Seq (Massive Analysis of cDNA Ends) technology that enables highly sensitive and efficient transcriptome profiling from low-input and degraded RNA samples. Their MACE-Seq technology is particularly valued for plant transcriptomics and RNA analysis from difficult biological matrices where conventional RNA sequencing methods perform suboptimally. GenXPro's technical innovation, scientific expertise in non-model organism transcriptomics, and collaborative research partnerships position them as a specialized and scientifically distinguished contributor to the global RNA analysis services landscape.

16. Lexogen GmbH

Lexogen GmbH is an Austrian RNA analysis specialist renowned for developing innovative RNA sequencing library preparation technologies—most notably the SENSE and QuantSeq product families—that enable highly accurate, strand-specific mRNA quantification with streamlined, low-input workflows. Their QuantSeq 3' mRNA-Seq kit has become a widely adopted cost-effective alternative to whole transcriptome sequencing for gene expression studies, providing efficient transcript quantification from minimal RNA inputs. Lexogen's scientific innovation in RNA library preparation chemistry, combined with their collaborative academic research partnerships and growing portfolio of miRNA, total RNA, and single-cell sequencing solutions, establishes them as a technically differentiated player in the RNA analysis reagent market.

17. Cenix BioScience GmbH

Cenix BioScience GmbH is a Dresden-based contract research organization specializing in RNA biology, RNAi screening, antisense oligonucleotide research, and transcriptomics services for pharmaceutical and biotechnology companies engaged in RNA-targeted drug discovery. Their expertise in functional genomics, siRNA and antisense drug target validation, and RNA analysis-driven drug discovery services provides biopharma clients with specialized RNA biology knowledge that accelerates the identification and characterization of RNA-based therapeutic targets. Cenix BioScience's long-standing track record in RNA drug discovery collaboration and their deep mechanistic understanding of RNA biology make them a scientifically distinctive partner in the RNA-focused pharmaceutical research service landscape.

18. Takara Holdings Inc.

Takara Holdings Inc., through its Takara Bio subsidiary, is a significant contributor to the RNA analysis market with a portfolio including SMART-Seq single-cell RNA amplification technologies, SMARTer RNA library preparation kits, and a broad range of reverse transcriptase and PCR reagents optimized for challenging low-input and single-cell RNA analysis workflows. Their SMART (Switching Mechanism at 5' end of RNA Template) technology has enabled a generation of transcriptomics researchers to generate full-length cDNA libraries from single cells and minute RNA quantities with unprecedented sensitivity. Takara Bio's Japanese scientific heritage, deep academic research partnerships, and continued investment in single-cell and spatial transcriptomics solutions support their growing global relevance in advanced RNA analysis.

19. bioMérieux SA

bioMérieux SA is a global leader in in vitro diagnostics with a growing RNA analysis portfolio spanning molecular diagnostic platforms, infectious disease RNA detection assays, and clinical transcriptomics tools that support both patient care and pharmaceutical research applications. Their BIOFIRE multiplex PCR panels and VIDAS immunoassay platforms incorporate RNA detection capabilities for rapid pathogen identification and host response analysis in clinical settings. bioMérieux's expanding investment in RNA-based host response diagnostics—using RNA expression signatures to guide antibiotic stewardship, sepsis management, and infectious disease treatment decisions—positions them as an innovative bridge between RNA analysis science and clinical diagnostic utility.

20. LC Sciences LLC

LC Sciences LLC is a US-based genomics services and microarray company offering specialized microRNA profiling, long non-coding RNA analysis, RNA sequencing, and custom microarray design services for academic and biopharmaceutical research customers. Their proprietary miRNA microarray platform and bioinformatics support services have earned a strong reputation in the non-coding RNA research community, where systematic profiling of miRNA expression patterns is a cornerstone of disease mechanism discovery and biomarker identification. LC Sciences' technical specialization in RNA microarray technology and their focus on the non-coding RNA analysis segment distinguish them as a niche but scientifically valued service provider in the broader RNA analysis market.

21. Oxford Nanopore Technologies

Oxford Nanopore Technologies has brought a transformative new capability to RNA analysis through its direct RNA sequencing technology, which enables sequencing of native RNA molecules without reverse transcription or amplification—preserving base modification information and enabling detection of RNA modifications such as m6A methylation that are invisible to conventional sequencing approaches. Their MinION, GridION, and PromethION platforms support direct RNA sequencing from diverse biological samples, enabling researchers to characterize the full complexity of the transcriptome including isoforms, modifications, and polyadenylation patterns in unprecedented detail. Oxford Nanopore's unique ability to sequence native RNA directly positions them as a pioneer in the emerging field of epitranscriptomics and full-length isoform transcriptomics.

22. Zymo Research Corporation

Zymo Research Corporation is a California-based life science company whose RNA isolation and purification technologies are widely used as the foundational sample preparation step in RNA analysis workflows across research and clinical laboratories. Their Quick-RNA and RNeasy-compatible products deliver high-purity RNA from a diverse range of biological matrices, while their ZymoBIOMICS RNA controls and standards support rigorous quality assurance in microbiome and metatranscriptomics research. Zymo Research's innovation in nucleic acid chemistry, commitment to product quality, and expanding portfolio of epigenomics and transcriptomics sample preparation tools support their growing relevance across the RNA analysis workflow from sample quality to sequencing-ready library preparation.

23. GeneDx

GeneDx is a leading clinical genomics and transcriptomics company that integrates RNA analysis into its comprehensive genetic testing services to improve diagnostic yield in rare disease, pediatric genetics, and cancer diagnostics programs. Their RNA splicing analysis capabilities—used to reclassify variants of uncertain significance by assessing their functional impact on transcript splicing—represent an important and growing clinical application of RNA analysis in diagnostic genetics. GeneDx's focus on clinically actionable genomic and transcriptomic insights, combined with their large-scale rare disease testing infrastructure and deep clinical genetics expertise, positions them as an innovative clinical RNA analysis player advancing precision diagnostics for patients with undiagnosed and complex genetic conditions.

24. Partek Incorporated

Partek Incorporated is a bioinformatics software company whose Partek Genomics Suite and Partek Flow platforms are widely used by researchers and clinical scientists to analyze, visualize, and interpret RNA sequencing and gene expression data generated from diverse transcriptomics experiments. Their intuitive graphical interface and comprehensive statistical analysis tools enable biologists without deep programming expertise to independently perform differential expression analysis, pathway enrichment, alternative splicing analysis, and single-cell transcriptomics data interpretation. Partek's focus on making complex RNA analysis data interpretation accessible to non-computational scientists fills a critical gap in the RNA analysis workflow and supports broader adoption of transcriptomics methodologies across the life science research community.

25. BGI Group

BGI Group is China's largest genomics organization and a globally significant RNA analysis player, offering large-scale RNA sequencing services, transcriptomics data analysis, and DNBseq-powered sequencing platforms that support mRNA, lncRNA, small RNA, and single-cell RNA analysis for research customers across academia, agriculture, and the pharmaceutical industry. BGI's proprietary DNBSEQ sequencing technology provides a cost-competitive platform for high-throughput transcriptomics projects, while their extensive bioinformatics infrastructure supports complex multi-sample and time-series RNA expression studies at scale. BGI's unmatched capacity for large-scale transcriptomics projects, competitive service pricing, and growing international scientific reputation position them as one of the most consequential RNA analysis service providers in the global market.